Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-18-012323)

Filing Details

Accession Number:: 0001225208-18-012323
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-08-06 15:19:23
Reporting Period:: 2018-08-03

Accepted Time:: 2018-08-06 15:19:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
78003	Pfizer Inc	PFE	Pharmaceutical Preparations (2834)	135315170

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1678459	R Alexander Mackenzie	Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017	Executive Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-08-03	100	$39.56	127,954	No	4	S	Direct
Common Stock	Disposition	2018-08-03	100	$39.52	127,854	No	4	S	Direct
Common Stock	Disposition	2018-08-03	2,100	$39.55	125,754	No	4	S	Direct
Common Stock	Disposition	2018-08-03	4,500	$39.53	121,254	No	4	S	Direct
Common Stock	Disposition	2018-08-03	6,400	$39.51	114,854	No	4	S	Direct
Common Stock	Disposition	2018-08-03	12,442	$39.50	102,412	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	9,120	Indirect	By Rule 16b-3 Plan